Prostate Cancer Foci Detected on Multiparametric Magnetic Resonance Imaging are Histologically Distinct From Those Not Detected
Abstract
Purpose:
We identified histological differences between prostate cancer foci that are detected and missed using multiparametric magnetic resonance imaging.
Materials and Methods:
A total of 49 patients who underwent multiparametric magnetic resonance imaging, including T2-weighted imaging, including diffusion weighted imaging and dynamic contrast enhanced imaging, before prostatectomy were enrolled in the study. One radiologist identified areas highly suspicious for tumor. One pathologist identified and categorized tumors in terms of size, Gleason score, solid tumor growth, intermixed benign glands, loose stroma, desmoplastic stroma and a high malignant epithelium-to-stroma ratio. Differences between detected and missed tumors were assessed using logistic regression analyses based on generalized estimating equations for correlated data.
Results:
All histological features showed significant differences between detected and missed tumors on multiparametric magnetic resonance imaging (p <0.0001). Independent predictors of detection on multivariate analysis were size (OR 5.38, p = 0.0077), Gleason score (OR 5.12, p = 0.0094) and solid growth (OR 17.83, p <0.0001). Size, Gleason score and loose stroma were significant predictors of identification with diffusion weighted imaging on univariate analysis (p ≤0.0245), while Gleason score (OR 17.05, p = 0.0212) and solid growth (OR 34.90, p = 0.0103) were independent predictors of identification with diffusion weighted imaging on multivariate analysis. Identification with T2-weighted imaging was associated with size and Gleason score (p ≤0.01876). Identification with dynamic contrast enhanced imaging was associated with intermixed benign epithelium, loose stroma and a high malignant epithelium-to-stroma ratio (p ≤0.0499). No combination of features served as independent predictors on multivariate analysis for T2-weighted imaging or dynamic contrast enhanced imaging.
Conclusions:
There are fundamental histological differences between detected and missed prostate tumors using magnetic resonance imaging. Insights into these differences may facilitate the prospective role of magnetic resonance imaging in counseling and treatment selection for patients with prostate cancer.
References
- 1 : Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation. Radiology2010; 255: 89. Google Scholar
- 2 : Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int2011; 108: E171. Google Scholar
- 3 : Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?. Radiology2011; 258: 488. Google Scholar
- 4 : Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least 1 transrectal US-guided biopsy with a negative finding–multiparametric MR imaging for detection and biopsy planning. Radiology2011; 259: 162. Google Scholar
- 5 : Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol2010; 58: 173. Google Scholar
- 6 : Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2–sparse versus dense cancers. Radiology2008; 249: 900. Google Scholar
- 7 : Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology2010; 257: 715. Google Scholar
- 8 : Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology2006; 239: 784. Google Scholar
- 9 : Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology2008; 248: 531. Google Scholar
- 10 : Prostate cancer: body-array versus endorectal coil MR imaging at 3 T–comparison of image quality, localization, and staging performance. Radiology2007; 244: 184. Google Scholar
- 11 : Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging2010; 31: 625. Google Scholar
- 12 : Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?. Eur Radiol2007; 17: 1498. Google Scholar
- 13 : Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol2007; 189: 323. Google Scholar
- 14 : Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol2007; 61: 297. Google Scholar
- 15 : “Stromatogenesis” and tumor progression. Int J Surg Pathol2004; 12: 1. Google Scholar
- 16 : Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology2010; 255: 485. Google Scholar
- 17 : Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int2009; 103: 883. Google Scholar
- 18 : Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging2009; 29: 1360. Google Scholar
- 19 : Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol2009; 44: 572. Google Scholar
- 20 : Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. Clin Radiol2008; 63: 153. Google Scholar
- 21 : Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology2009; 252: 449. Google Scholar
- 22 : Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology2010; 256: 176. Google Scholar
- 23 : Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol2011; 21: 1111. Google Scholar
- 24 : A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol2009; 56: 981. Google Scholar
- 25 : Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal–pelvic phased-array coils. Radiology1994; 193: 703. Google Scholar
